Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR17 Emtricitabine and tenofoviralafenamide
D10835 Emtricitabine and tenofovir alafenamide <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Combinations
Emtricitabine/ Tenofovir Alafenamide Fumarate
D10835 Emtricitabine and tenofovir alafenamide
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D10835 Emtricitabine and tenofovir alafenamide
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D10835 Emtricitabine and tenofovir alafenamide
DG03107 Anti-HIV agent
D10835 Emtricitabine and tenofovir alafenamide
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D10835 Emtricitabine and tenofovir alafenamide
Transporter substrate
DG01665 ABCB1 substrate
D10835 Emtricitabine and tenofovir alafenamide
DG03001 CTSA substrate
D10835 Emtricitabine and tenofovir alafenamide
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D10835 Emtricitabine and tenofovir alafenamide
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D10835 Emtricitabine and tenofovir alafenamide <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10835
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10835
Drug transporters
D10835